1Olayioye MA, Neve RM, Lane HA, et al. The erbB signaling network: receptor heterodimerization in development and cancer [J]. EMBO J, 2000, 19(13) : 3159-3167.
2Sliwkowski MX, Lofgren JA, Lewis GD, et al. Nonclinical studies addressing the mechanism of action of Trastuzumb(Herception) [J]. Semin Oncol, 1999, 26(4): 60-70.
3Tzahar E, Moyer JD, Waterman H, et al. Pathogenic poxviruses reveal viral strategies to exploit the erbB signaling network [J]. EMBOJ, 1998, 17 (20): 5948-5963.
4Graus Porta D, Beerli RR, Daly JM, et al. erbB-2, the preferred heterodimerization partner of all erbB receptors, is a mediator of lateral signaling [J]. EMBOJ, 1997, 16(7): 1647-1655.
5Zvibel I, Brill S, Halpem Z, et al. Soluble and matrix-associated heparan sulfate proteoglycans increase expression of erbB-2 and erbB-3 in colon cancer cell lines [J]. Int J Cancer, 2001, 91(3): 316-321.
6Spencer KSR, Graus Porta D, Leng J, et al. erbB-2 is necessary for induction of carcinoma cell invasion by erbB family receptor tyrosine kinases [J]. J Cell Biol, 2000, 148(2): 385-397.
7Olayioye MA, Beuvink I, Horsch K, et al. erbB receptor-induced activation of stat transcription factors is mediated by Src tyrosine kinases [J]. J Biol Chem, 1999, 274(24): 17209-17218.
8Bridges AJ. The rationale and strategy used to develop a series of highly potent, irreversible, inhibitors of the epidermal growth factor receptor family of tyrosine kinases [J]. Curr Med Chem, 1999, 6 (9) : 825-843.
9Srinivasan R, Poulson R, Hurst HC, et al. Expression of the c-erbB-4/HER4 protein and mRNA in normal human fetal and adult tissues and in a survey of nine sold tumor types [J]. J Pathol, 1998, 185(3) : 236-245.
10Travis A, Pinder SE, Robert JFR, et al. C-erbB-3 in human breast carcinoma: expression and related to prognosis and established prognostic indicators [J]. Br J Cancer, 1996, 74(2): 229-233.
